Qiagen N.V. (QGEN) Discusses Digital PCR Technology and Applications in Environmental Sample Analysis June 15, 2026 10:00 AM EDT
Company Participants
Domenica Martorana – Associate Director of Global Investor Relations
Nitin Sood – Senior VP & Head of Product Portfolio & Innovation
Fernando Beils
Thierry Bernard – CEO, MD & Member of Management Board
Daniel Wendorff – VP & Head of Investor Relations
Jonathan Sheldon
Presentation
Domenica Martorana
Associate Director of Global Investor Relations
Hello, and welcome to our next deep dive. Today, it’s all about QIAcuity digital PCR. We’re going to answer questions around what is digital PCR, how does it compare with quantitative PCR and how does sequencing fit in. But before we begin, a quick legal note, as with any investor event, this presentation includes a safe harbor statement. You’re likely familiar with this from our other presentations, so I won’t read it in full. However, please remember that we will be making forward-looking statements. Actual results may differ materially from those projected, and the factors driving those are detailed in our most recent Form 20-F filed with the Securities and Exchange Commission. A copy is also available on our web page.
Let’s now have a closer look into how DPCR, qPCR and NGS differ and why it matters. Huw Ricketts our Head of Global Digital PCR and Francesca Di Pasquale, our Head of Digital PCR R&D are going to take us on this journey.
Huw what are we doing here by the lake? I thought we’re going to talk about digital PCR.
Unknown Executive
I know we are, but I thought this would be a great location to talk about it. Earlier, I collected this water sample from the lake here, but don’t worry, German waterways are generally pretty clean but this water sample could still contain traces of wastewater.

